European Heart Journal Advance Access published online on April 12, 2006
European Heart Journal, doi:10.1093/eurheartj/ehi884
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Duke Clinical Research Institute and Duke University Medical Center, PO Box 17969, Durham, NC 27715, USA
* To whom correspondence should be addressed. Aims In acute myocardial infarction (AMI), baseline hyperglycaemia predicts adverse outcomes, but the relation between subsequent change in glucose levels and outcomes is unclear. We evaluated the prognostic significance of baseline glucose and the change in glucose in the first 24 h following AMI. Methods and results We analysed 1469 AMI patients with baseline and 24 h glucose data from the CARDINAL trial database. Baseline glucose and the 24 h change in glucose (24 h glucose level subtracted from baseline glucose) were included in multivariable models for 30- and 180-day mortality. By 30 and 180 days, respectively, 45 and 74 patients had died. In the multivariable 30-day mortality model, neither baseline glucose nor the 24 h change in glucose predicted mortality in diabetic patients (n=250). However, in nondiabetic patients (n=1219), higher baseline glucose predicted higher mortality [hazard ratio (HR) 1.12, 95% confidence interval (CI) 1.04-1.20, per 0.6 mmol/L increase], and a greater 24 h change in glucose predicted lower mortality (HR 0.91, 95% CI 0.86-0.96, for every 0.6 mmol/L drop in glucose in the first 24 h) at 30 days. Baseline glucose and the 24 h change in glucose remained significant multivariable mortality predictors at 180 days in nondiabetic patients. Conclusion Both higher baseline glucose and the failure of glucose levels to decrease in the first 24 h after AMI predict higher mortality in nondiabetic patients.
Received October 19, 2005
Revised March 17, 2006
Accepted March 23, 2006
Clinical research
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study
Abhinav Goyal 1 *,
Kenneth W. Mahaffey 1,
Jyotsna Garg 1,
Jose C. Nicolau 2,
Judith S. Hochman 3,
W. Douglas Weaver 4,
Pierre Theroux 5,
Gustavo B.F. Oliveira 6,
Thomas G. Todaro 7,
Christopher F. Mojcik 8,
Paul W. Armstrong 9,
and
Christopher B. Granger 1
2 Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil
3 Columbia University, New York, NY, USA
4 Henry Ford Hospital, Detroit, MI, USA
5 Montreal Heart Institute, Montreal, Quebec, Canada
6 Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
7 Procter & Gamble Pharmaceuticals, Mason, OH, USA
8 Alexion Pharmaceuticals, Inc., Cheshire, CT, USA
9 University of Alberta, Edmonton, Alberta, Canada
Abhinav Goyal, E-mail: a.goyal{at}duke.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. S. Moghissi, M. T. Korytkowski, M. DiNardo, D. Einhorn, R. Hellman, I. B. Hirsch, S. E. Inzucchi, F. Ismail-Beigi, M. S. Kirkman, and G. E. Umpierrez American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control Diabetes Care, June 1, 2009; 32(6): 1119 - 1131. [Full Text] [PDF] |
||||
![]() |
R Anantharaman, M Heatley, and C F M Weston Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target? Heart, May 1, 2009; 95(9): 697 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dandona, A. Chaudhuri, and H. Ghanim Acute Myocardial Infarction, Hyperglycemia, and Insulin J. Am. Coll. Cardiol., April 21, 2009; 53(16): 1437 - 1439. [Full Text] [PDF] |
||||
![]() |
M. Kosiborod, S. E. Inzucchi, A. Goyal, H. M. Krumholz, F. A. Masoudi, L. Xiao, and J. A. Spertus Relationship Between Spontaneous and Iatrogenic Hypoglycemia and Mortality in Patients Hospitalized With Acute Myocardial Infarction JAMA, April 15, 2009; 301(15): 1556 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kosiborod, S. E. Inzucchi, H. M. Krumholz, F. A. Masoudi, A. Goyal, L. Xiao, P. G. Jones, S. Fiske, and J. A. Spertus Glucose Normalization and Outcomes in Patients With Acute Myocardial Infarction Arch Intern Med, March 9, 2009; 169(5): 438 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Sinnaeve, P. G. Steg, K. A. A. Fox, F. Van de Werf, G. Montalescot, C. B. Granger, E. Knobel, F. A. Anderson, O. H. Dabbous, A. Avezum, et al. Association of Elevated Fasting Glucose With Increased Short-term and 6-Month Mortality in ST-Segment Elevation and Non-ST-Segment Elevation Acute Coronary Syndromes: The Global Registry of Acute Coronary Events Arch Intern Med, February 23, 2009; 169(4): 402 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Gerstein Dysglycemia and Cardiovascular Risk in the General Population Circulation, February 17, 2009; 119(6): 773 - 775. [Full Text] [PDF] |
||||
![]() |
M. Kosiborod Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 269 - 275. [Abstract] [PDF] |
||||
![]() |
A. Goyal, K. Nerenberg, H. C Gerstein, G. Umpierrez, and P. W. Wilson Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 276 - 284. [Abstract] [PDF] |
||||
![]() |
A. Goyal, R. Diaz, and S. R. Mehta Glucose-Insulin-Potassium Therapy in Patients With STEMI--Reply JAMA, May 28, 2008; 299(20): 2387 - 2388. [Full Text] [PDF] |
||||
![]() |
R. A. Kloner and R. W. Nesto Glucose-Insulin-Potassium for Acute Myocardial Infarction: Continuing Controversy Over Cardioprotection Circulation, May 13, 2008; 117(19): 2523 - 2533. [Full Text] [PDF] |
||||
![]() |
U. N. Das Glucose, insulin, and coronary heart disease Eur. Heart J., April 2, 2008; 29(8): 1075 - 1076. [Full Text] [PDF] |
||||
![]() |
P. Deedwania, M. Kosiborod, E. Barrett, A. Ceriello, W. Isley, T. Mazzone, and P. Raskin Hyperglycemia and Acute Coronary Syndrome: A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism Circulation, March 25, 2008; 117(12): 1610 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Nesto and R. M. Lago Glucose: A Biomarker in Acute Myocardial Infarction Ready for Prime Time? Circulation, February 26, 2008; 117(8): 990 - 992. [Full Text] [PDF] |
||||
![]() |
M. Kosiborod, S. E. Inzucchi, H. M. Krumholz, L. Xiao, P. G. Jones, S. Fiske, F. A. Masoudi, S. P. Marso, and J. A. Spertus Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk Circulation, February 26, 2008; 117(8): 1018 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mudespacher, D. Radovanovic, E. Camenzind, M. Essig, O. Bertel, P. Erne, F. R. Eberli, and F. Gutzwiller Admission glycaemia and outcome in patients with acute coronary syndrome Diabetes and Vascular Disease Research, December 1, 2007; 4(4): 346 - 352. [Abstract] [PDF] |
||||
![]() |
A. Chaudhuri, M. Miller, R. Nesto, N. Rosenberg, and P. Dandona Targeting Glucose in Acute Myocardial Infarction: Has glucose, insulin, and potassium infusion missed the target? Diabetes Care, December 1, 2007; 30(12): 3026 - 3028. [Full Text] [PDF] |
||||
![]() |
S. W. Zarich and R. W. Nesto Implications and Treatment of Acute Hyperglycemia in the Setting of Acute Myocardial Infarction Circulation, May 8, 2007; 115(18): e436 - e439. [Full Text] [PDF] |
||||
![]() |
D. Aronson, H. Hammerman, M. R. Kapeliovich, A. Suleiman, Y. Agmon, R. Beyar, W. Markiewicz, and M. Suleiman Fasting Glucose in Acute Myocardial Infarction: Incremental value for long-term mortality and relationship with left ventricular systolic function Diabetes Care, April 1, 2007; 30(4): 960 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Goyal, K. W. Mahaffey, J. Garg, J. C. Nicolau, J. S. Hochman, W. D. Weaver, G. B.F. Oliveira, T. T. Todaro, and C. B. Granger Glucose, insulin, and acute myocardial infarction: reply Eur. Heart J., September 1, 2006; 27(17): 2142 - 2143. [Full Text] [PDF] |
||||
![]() |
U. N. Das Glucose, insulin, and acute myocardial infarction Eur. Heart J., September 1, 2006; 27(17): 2141 - 2142. [Full Text] [PDF] |
||||
![]() |
M. Vogelzang and F. Zijlstra Glucose metabolism and acute myocardial infarction Eur. Heart J., June 1, 2006; 27(11): 1264 - 1265. [Full Text] [PDF] |
||||







